Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013 (2013), Article ID 589474, 10 pages
http://dx.doi.org/10.1155/2013/589474
Research Article

Impact of High Glucose and Proteasome Inhibitor MG132 on Histone H2A and H2B Ubiquitination in Rat Glomerular Mesangial Cells

Department of Endocrinology, Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China

Received 28 October 2012; Revised 12 January 2013; Accepted 17 February 2013

Academic Editor: Aimin Xu

Copyright © 2013 Chenlin Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Hu, R. Zhang, W. Yu et al., “CPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients,” Diabetes, vol. 60, no. 11, pp. 3085–3089, 2011. View at Google Scholar
  2. D. Choudhury, M. Tuncel, and M. Levi, “Diabetic nephropathy—a multifaceted target of new therapies,” Discovery Medicine, vol. 10, no. 54, pp. 406–415, 2010. View at Google Scholar · View at Scopus
  3. N. A. Calcutt, M. E. Cooper, T. S. Kern, and A. M. Schmidt, “Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials,” Nature Reviews Drug Discovery, vol. 8, no. 5, pp. 417–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. V. D'Agati and A. M. Schmidt, “RAGE and the pathogenesis of chronic kidney disease,” Nature Reviews Nephrology, vol. 6, no. 6, pp. 352–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. E. Declèves and K. Sharma, “New pharmacological treatments for improving renal outcomes in diabetes,” Nature Reviews Nephrology, vol. 6, no. 6, pp. 371–380, 2010. View at Google Scholar
  6. P. Ruggenenti, P. Cravedi, and G. Remuzzi, “Optimizing allocation of kidneys from older donors,” American Journal of Transplantation, vol. 11, no. 1, pp. 182–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Villeneuve, M. A. Reddy, and R. Natarajan, “Epigenetics: deciphering its role in diabetes and its chronic complications,” Clinical and Experimental Pharmacology Physiology, vol. 38, no. 7, pp. 451–459, 2011. View at Google Scholar
  8. S. Tonna, A. El-Osta, M. E. Cooper, and C. Tikellis, “Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms,” Nature Reviews Nephrology, vol. 6, no. 6, pp. 332–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Sun, M. A. Reddy, H. Yuan, L. Lanting, M. Kato, and R. Natarajan, “Epigenetic histone methylation modulates fibrotic gene expression,” Journal of the American Society of Nephrology, vol. 21, no. 12, pp. 2069–2080, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kouzarides, “Chromatin modifications and their function,” Cell, vol. 128, no. 4, pp. 693–705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Higashi, S. Inoue, and T. Ito, “Core histone H2A ubiquitylation and transcriptional regulation,” Experimental Cell Research, vol. 316, no. 17, pp. 2707–2712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Brasacchio, J. Okabe, C. Tikellis et al., “Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail,” Diabetes, vol. 58, no. 5, pp. 1229–1236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. El-Osta, D. Brasacchio, D. Yao et al., “Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia,” The Journal of Experimental Medicine, vol. 205, no. 10, pp. 2409–2417, 2008. View at Google Scholar
  14. A. L. Siebel, A. Z. Fernandez, and A. El-Osta, “Glycemic memory associated epigenetic changes,” Biochemical Pharmacology, vol. 80, no. 12, pp. 1853–1859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Villeneuve, M. Kato, M. A. Reddy, M. Wang, L. Lanting, and R. Natarajan, “Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1,” Diabetes, vol. 59, no. 11, pp. 2904–2915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Noh, E. Y. Oh, J. Y. Seo et al., “Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-β1-induced renal injury,” American Journal of Physiology—Renal Physiology, vol. 297, no. 3, pp. F729–F738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Anand and R. Marmorstein, “Structure and mechanism of lysine-specific demethylase enzymes,” The Journal of Biological Chemistry, vol. 282, no. 49, pp. 35425–35429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ma, B. Chen, D. Liu et al., “MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway,” Biochemical Pharmacology, vol. 81, no. 10, pp. 1228–1236, 2011. View at Google Scholar
  19. D. Fang, H. Guan, J. Liu et al., “Early intensive insulin therapy attenuates the p38 pathway in the renal cortex and indices of nephropathy in diabetic rats,” Endocrine Journal, vol. 59, no. 1, pp. 81–90, 2012. View at Google Scholar
  20. P. D. Gluckman, M. A. Hanson, T. Buklijas, F. M. Low, and A. S. Beedle, “Epigenetic mechanisms that underpin metabolic and cardiovascular diseases,” Nature Reviews Endocrinology, vol. 5, no. 7, pp. 401–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Mitić and C. Emanueli, “Diabetes-induced epigenetic signature in vascular cells,” Endocrine, Metabolic & Immune Disorders Targets, vol. 12, no. 2, pp. 107–117, 2012. View at Google Scholar
  22. R. E. Gilbert, Q. Huang, K. Thai et al., “Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor,” Kidney International, vol. 79, no. 12, pp. 1312–1321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Reddy and R. Natarajan, “Epigenetics in diabetic kidney disease,” Journal of the American Society of Nephrology, vol. 22, no. 12, pp. 2182–2185, 2011. View at Google Scholar
  24. C. S. Kadiyala, L. Zheng, Y. Du et al., “Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC),” The Journal of Biological Chemistry, vol. 287, no. 31, pp. 25869–25880, 2012. View at Google Scholar
  25. H. Yuan, M. A. Reddy, G. Sun et al., “Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1 mediated gene transcription in mesangial cells,” American Journal of Physiology—Renal Physiology, vol. 304, no. 5, pp. F601–F613, 2013. View at Google Scholar
  26. R. V. Intine and M. P. Sarras Jr., “Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms,” Current Diabetise Reports, vol. 12, no. 5, pp. 551–519, 2012. View at Google Scholar
  27. S. T. Keating and A. El-Osta, “Chromatin modifications associated with diabetes,” Journal of Cardiovascular Translational Research, vol. 5, no. 4, pp. 399–412, 2012. View at Google Scholar
  28. M. Guha, Z. G. Xu, D. Tung, L. Lanting, and R. Natarajan, “Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes,” The Federation of American Societies for Experimental Biology Journal, vol. 21, no. 12, pp. 3355–3368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Shi and J. Massagué, “Mechanisms of TGF-β signaling from cell membrane to the nucleus,” Cell, vol. 113, no. 6, pp. 685–700, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Fineschi, W. Reith, P. A. Guerne, J. M. Dayer, and C. Chizzolini, “Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts,” The Federation of American Societies for Experimental Biology Journal, vol. 20, no. 3, pp. 562–564, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Takiyama, T. Harumi, J. Watanabe et al., “Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism,” Diabetes, vol. 60, no. 3, pp. 981–992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Wang, Y. Xu, X. Fang et al., “Effects of MG132 on FNmRNA expression in early diabetic nephropathy rats,” Chinese Pharmacological Bulletin, vol. 27, no. 12, pp. 1773–1774, 2011. View at Google Scholar
  33. T. Sakairi, K. Hiromura, S. Takahashi et al., “Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo,” Nephrology, vol. 16, no. 1, pp. 76–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. C. H. Choi, B. H. Lee, S. G. Ahn, and S. H. Oh, “Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β,” Biochemical and Biophysical Research Communications, vol. 418, no. 4, pp. 759–764, 2012. View at Google Scholar
  35. A. Zanotto-Filho, E. Braganhol, A. M. Battastini et al., “Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling,” Investigational New Drugs, vol. 30, no. 6, pp. 2252–2262, 2012. View at Google Scholar
  36. C. Saji, C. Higashi, Y. Niinaka, K. Yamada, K. Noguchi, and M. Fujimuro, “Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells,” Biochemical and Biophysical Research Communications, vol. 415, no. 4, pp. 573–578, 2011. View at Google Scholar
  37. B. O. Strøm and R. E. Paulsen, “Apoptosis inducer NGFI-B is degraded by the proteasome and stabilized by treatment with EGF,” Biochemical and Biophysical Research Communications, vol. 417, no. 4, pp. 1292–1297, 2012. View at Google Scholar
  38. V. S. Thakur, K. Gupta, and S. Gupta, “Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases,” International Journal of Oncology, vol. 33, no. 2, pp. 377–384, 2012. View at Google Scholar